Skip to main content
OpenTrials
Completed

NCT Number: NCT05556980

Totally Laparoscopic Distal Gastrectomy for Gastric Cancer

This study was designed as a randomized clinical trial comparing the totally laparoscopic distal gastrectomy with laparoscopy-assisted distal gastroectomy for patients with gastric cancer, in terms of short-term and long-term outcomes.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Xubing Zhang

Hefei, Other (Non U.s.), 230001, China

About this study

When one patient was enrolled, he will be randomly divided into experimental group (totally laparoscopic distal gastrectomy) or control group (laparoscopy-assisted distal gastrectomy). When he receives surgery, intraoperative parameters would be recorded. when the patient discharges, the routine follow-up would be regularly performed for the survival.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • aged 18-80 years old, no gender limitation;
  • primary gastric cancer and planed for distal gastrectomy;

Exclusion criteria

  • patients with total or proximal gastrectomy;
  • patients with distant metastasis.

Treatment and study plan

totally laparoscopic distal gastrectomy

Procedure

all the surgical procedure would be finished under laparoscopy

Primary outcomes

  1. postoperative stay

    Time frame: about one week to one month from the finish of surgery

    the time from the finish of surgery to discharge

Secondary outcomes

  1. Survival

    Time frame: 3 year

    the survival rate at the third year from the finish of surgery

Sponsors and collaborators

Lead sponsor

Liu Liu

Other

Registry information

Official study title

Randomized Controlled Trial Comparing the Outcomes of Totally Laparoscopic Distal Gastrectomy and Laparoscopy-assisted Gastrectomy for Gastric Cancer

Acronym: TLDG

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Sep 27, 2022
Registry last updated
Sep 25, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.